Navigation Links
Novan's SB204 Could Be First Topical Sebum Inhibitor
Date:2/28/2013

DURHAM, N.C., Feb. 28, 2013 /PRNewswire/ -- Novan Therapeutics, a clinical-stage drug development company, today announced in vitro and animal testing data indicating that the company's drug candidate, SB204, could lead to a topical treatment to reduce oil production in the skin.  SB204 is being developed as a new therapy for acne which is the most common skin disease in the United States, affecting more than 50 million people. 

(Logo: http://photos.prnewswire.com/prnh/20130228/NE68367LOGO )

None of the current topical products approved by the FDA reduce the production of sebum, the oily/waxy secretions of the skin.  Dr. Diane Thiboutot , Professor of Dermatology at Penn State Hershey College of Medicine, believes "Inhibiting the production of sebum is critical to affecting the acne disease process.  Orally administered therapies that can reduce oily secretions of the skin have traditionally shown good clinical responses.  At this time, I am not aware of any topically applied therapy that can reduce sebum production."

Novan-sponsored research conducted in the lab of Dr. Thiboutot revealed that nitric oxide-releasing compounds could reduce sebum production in vitro using immortalized human sebocytes.  The study results demonstrated that Novan's drug candidate showed a statistically significant decrease in insulin-induced lipid production as early as 24 hours after a single treatment.   

In a separate study to further expand upon the company's unique discovery, topical application of nitric oxide-releasing SB204 inhibited the growth of a hamster flank organ by more than 50% compared to vehicle control.  "We are really excited about these results because this now gives us two potential pathways by which SB204 can shut down the production of sebum in the skin," said company President Dr. Nathan Stasko .  The golden Syrian hamster flank organ model has historically been used to assess the anti-androgenic activity of experimental therapeutics.  The overproduction of androgens in the skin has been linked to the overproduction of sebum and worsening of acne.

Novan expects to begin enrolling subjects in a Phase 2 study for the treatment of acne in the second quarter of this year.  This clinical study will evaluate the safety and efficacy of SB204 as well as the topical therapy's ability to decrease sebum in the skin of subjects.  Dr. Stasko commented, "We have invested significant resources to develop methods for the clinical evaluation of sebum in the skin.  SB204 could be an attractive topical acne treatment and what we believe will be the first of many innovative products for the field of dermatology."

About Novan, Inc.

Novan Inc., based in the Research Triangle Park area of North Carolina, is a clinical-stage drug development company harnessing the power of nitric oxide.  Nitric oxide, one of the most studied molecules in human physiology, has been confirmed to promote vasodilation, regulate inflammation, revitalize tissue, kill invading microorganisms, and even eradicate cancer.  The company's proprietary platform technology enables the stable storage of nitric oxide and the ability to deliver its healing power to patients in a variety of dosage forms.  Novan is currently developing innovative, first-in-class therapies for the field of dermatology. 

For more information, please contact:

Julia Brannan 
Pascale Communications 
201-725-7375 
novan@pascalecommunications.com  
www.novantherapeutics.com


'/>"/>
SOURCE Novan Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. New Report: Drugstore Networks Could Save Employers, Medicare, and Medicaid $115 Billion
2. Breakthrough Research Could Create Sea Change in Global HIV Diagnosis: New Handheld Mobile Device Performs Laboratory-Quality HIV Testing
3. Pen Pals, Glowing Parasites & Crop Camouflage Could Help Improve Lives
4. Back to School Ideas: Vaccines for Kids Could Hurt Rather Than Help Fight Disease
5. HIV Immunity Study Could Pave Way for Vaccine Development
6. Hearing Loss Could Lead to Multiple Chronic Diseases for Millions of Brits
7. Ochsner Implants First Total Artificial Heart In The Gulf South Region
8. London Health Sciences Centre Announces Firsts in Treatment Option for Blood Circulation
9. Ixonos auttaa Firstbeatia parantamaan syketallentimensa suorituskykyä ja helppokäyttöisyyttä
10. Ixonos Helps Firstbeat to Boost the Performance and Usability of Their Heart Beat Recording Device
11. New Bioterrorism Vaccine Gets First Test In Humans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... , May 4, 2016 According to ... Growth and Demand Forecast to 2022 - Industry Insights by ... Diagnostic Center and Others)" by P&S Market Research, the global ... in 2015, and it is expected to grow at a ... high slice type segment is expected to witness the faster ...
(Date:5/4/2016)... May 4, 2016 In ... a series of free workshops across ... requirements for Good Distribution Practices (GDP). Good ... ensures that products are consistently stored, transported and handled ... (MA) or product specification. Only a few years ago, ...
(Date:5/4/2016)... , May 4, 2016 ... of the  "Global Multiple Myeloma Market and ... their offering.       (Logo: ... Market and Competitive Landscape Highlights 2016, provides ... Multiple Myeloma epidemiology, Multiple Myeloma market valuations ...
Breaking Medicine Technology:
(Date:5/6/2016)... (PRWEB) , ... May 06, 2016 , ... ... of a master charity program created to support and assist the people of ... days, working closely with nonprofit organizations and community leaders. Their desire is to ...
(Date:5/6/2016)... York (PRWEB) , ... May 06, 2016 , ... A wide variety of national pet ... Events Home, Garden and Safety Media Showcase Wednesday, May 18 from noon to 8 p.m. ... offers a sneak peek at new and established home, garden, outdoor and safety pet products ...
(Date:5/6/2016)... ... May 06, 2016 , ... Online HR/benefits platforms offer a range of benefits ... traditional brokers and health plans. “ The Rapid Emergence of Online Benefits Firms: Strategies ... Services, Inc. (AIS), will offer an accurate picture of online benefits today, and the ...
(Date:5/6/2016)... ... May 06, 2016 , ... Expert mattress researchers ... Since launching in September, 2014 Sleepopolis has resided at Sleepopolis-mattress-reviews.com . The ... pillows, sheets, mattress toppers, bed frames, and more. , Founder and Editor-in-Chief Derek ...
(Date:5/6/2016)... ... 2016 , ... This Mother’s Day kicks off the start of an important ... Women’s Health Week takes place May 8-May 14. , Throughout the celebration, the ... women to make their health a top priority. Women everywhere are being encouraged to ...
Breaking Medicine News(10 mins):